Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
IXICO is a global leader in neuroimaging and biomarker analytics, providing precision imaging biomarker insights for neurological disease research. Its proprietary IXI™ platform uses AI to manage clinical trial data, read radiological scans, and measure key biomarkers for conditions like Alzheimer’s, Huntington’s, and Parkinson’s disease.
Parse Score